Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Dow
Cantor Fitzgerald
Baxter
Chubb
Medtronic
Mallinckrodt
AstraZeneca
Colorcon

Generated: April 24, 2018

DrugPatentWatch Database Preview

VIVACTIL Drug Profile

« Back to Dashboard

When do Vivactil patents expire, and when can generic versions of Vivactil launch?

Vivactil is a drug marketed by Odyssey Pharms and Teva Womens and is included in three NDAs.

The generic ingredient in VIVACTIL is protriptyline hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
Drug patent expirations by year for VIVACTIL
Medical Subject Heading (MeSH) Categories for VIVACTIL
Synonyms for VIVACTIL
1225-55-4 (HYDROCHLORIDE)
3-(11H-dibenzo[[?],[?]][7]annulen-11-yl)-N-methyl-propan-1-amine
3-(11H-dibenzo[1,2-a:1',2'-e][7]annulen-11-yl)-N-methylpropan-1-amine
3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine
3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine
3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine #
438-60-8
4NDU154T12
5-(3-Methylaminopropyl)-5H-dibenzo(a,d)cycloheptene
5-(3-Methylaminopropyl)-5H-Dibenzo[a,d]cycloheptene
5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-
5H-Dibenzo(a,d)cycloheptene-5-propylamine, N-methyl-
5H-Dibenzo[a, d]cycloheptene-5-propanamine, N-methyl-, hydrochloride
5H-Dibenzo[a,d]cycloheptene-5-propanamine, N-methyl-
5H-Dibenzo[a,d]cycloheptene-5-propylamine, N-methyl-
7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene
AB00489964
AB00489964_10
AC-15971
AC1L1JCC
ACM438608
AKOS015962184
Amimetilina
AN-5942
Apo-Imipramine
Apo-Trimip
BDBM50176062
BIDD:PXR0157
BPBio1_000924
BRD-K42098891-003-03-1
BRN 2217411
BSPBio_000840
BWPIARFWQZKAIA-UHFFFAOYSA-N
C07408
CAS-1225-55-4
CCG-205054
CHEBI:8597
CHEMBL668
Concordin
Concordin (Salt/Mix)
D00MYQ
D08447
DB00344
DTXSID0023535
EINECS 207-119-9
GTPL7285
HSDB 3391
Impril
L000913
Lopac-P-8813
Lopac0_000974
LP088948
LS-60771
Maximed
MCULE-6023848462
methyl(3-{tricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl}propyl)amine
METHYL(3-{TRICYCLO[9.4.0.0(3),?]PENTADECA-1(11),3(8),4,6,9,12,14-HEPTAEN-2-YL}PROPYL)AMINE
MK 240
MK-240
N-3-(5H-Dibenzo(a,d)cyclohepten-5-yl)propyl-N-methylamine
N-Methyl-5H-dibenzo(a,d)cycloheptene-5-propylamine
N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine
N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine
NCGC00015851-01
NCGC00015851-02
NCGC00015851-03
NCGC00015851-04
NCGC00015851-05
NCGC00015851-06
NCGC00015851-07
NCGC00024439-03
Normethyl EX4442
Novo-Doxepin
Novo-Tripramine
Novopramine
NSC169912
PDSP1_001390
PDSP2_001374
PL004578
Prestwick0_000930
Prestwick1_000930
Prestwick2_000930
Prestwick3_000930
Protriptilina
Protriptilina [INN-Spanish]
Protriptylin
protriptyline
Protriptyline (INN)
Protriptyline [INN:BAN]
Protriptylinum
Protriptylinum [INN-Latin]
Protryptyline
PROTRYPTYLINE HYDROCHLORIDE
SBI-0050947.P002
SCHEMBL34267
SPBio_003019
Triadapin 5
Triptil
Triptil hydrochloride
Triptyl
UNII-4NDU154T12
Vivactil (Salt/Mix)
Vivactil (TN)
Vivactyl
ZINC1530764

US Patents and Regulatory Information for VIVACTIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Odyssey Pharms VIVACTIL protriptyline hydrochloride TABLET;ORAL 073644-001 Aug 24, 1995 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Womens VIVACTIL protriptyline hydrochloride TABLET;ORAL 016012-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Odyssey Pharms VIVACTIL protriptyline hydrochloride TABLET;ORAL 073645-001 Aug 24, 1995 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Womens VIVACTIL protriptyline hydrochloride TABLET;ORAL 016012-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
AstraZeneca
Queensland Health
Julphar
Harvard Business School
US Department of Justice
Medtronic
QuintilesIMS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.